Patients born with heart defects experience their first acute heart attack at a significantly earlier age than others. This ...
A tool developed by the American Heart Association (AHA), proven to accurately predict heart disease risk for Americans, can ...
Integrated gut microbiome and plasma metabolomics profiling identified distinct microbial and metabolic signatures in people ...
May 5 (Reuters) - Cytokinetics said on Tuesday its experimental heart disease drug significantly improved symptoms of a genetic heart condition in a late-stage trial. Shares of the company were up 13.
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized yet frequently underdiagnosed cause of heart ...
A decades-long study of nearly 200,000 adults challenges the low-carb versus low-fat debate. Both eating patterns were tied to lower heart disease risk when they emphasized whole grains, plant-based ...
A Cytokinetics heart disease drug — already approved in one indication — succeeded in another Phase 3 trial, a potential boost for sales.
Background Real-life data is very useful for gaining a better understanding of care in practice and identifying areas for ...
Exercise can improve heart health and recovery outcomes for people with heart valve disease, but the the type of exercise depends on the specific valve condition and its severity. Safe exercise ...
Screening for heart failure with an AI-ECG algorithm could be particularly useful in places with limited access to more ...
Columbus-based OhioHealth has tested an AI tool that flags echocardiogram results to accelerate evaluation and treatment of valvular heart disease. Findings from the ALERT trial were published March ...
Heart valve diseases affect how blood flows through the heart muscle. Symptoms of heart valve disease can be subtle or develop slowly over time, with extreme fatigue often being the first sign.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results